Development
Cardlytics, Inc.
CDLX
$1.79
$0.116.55%
NASDAQ
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | 309.20M | 302.54M | 296.24M | 294.95M | 298.54M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 309.20M | 302.54M | 296.24M | 294.95M | 298.54M |
Cost of Revenue | 178.83M | 178.34M | 181.88M | 184.13M | 186.01M |
Gross Profit | 130.38M | 124.20M | 114.37M | 110.81M | 112.53M |
SG&A Expenses | 116.24M | 125.51M | 134.05M | 145.54M | 156.59M |
Depreciation & Amortization | 26.46M | 26.61M | 31.09M | 34.25M | 37.54M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 372.87M | 384.01M | 401.89M | 417.52M | 434.48M |
Operating Income | -63.67M | -81.47M | -105.65M | -122.58M | -135.94M |
Income Before Tax | -134.70M | -412.15M | -381.91M | -486.14M | -466.71M |
Income Tax Expenses | -- | 0.00 | 0.00 | -1.45M | -1.45M |
Earnings from Continuing Operations | -134.70 | -412.15 | -381.91 | -484.69 | -465.26 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -134.70M | -412.15M | -381.91M | -484.69M | -465.26M |
EBIT | -63.67M | -81.47M | -105.65M | -122.58M | -135.94M |
EBITDA | -37.21M | -54.86M | -74.56M | -88.33M | -98.39M |
EPS Basic | -3.46 | -12.22 | -11.40 | -14.48 | -13.90 |
Normalized Basic EPS | -1.10 | -1.41 | -1.94 | -2.39 | -2.71 |
EPS Diluted | -3.47 | -12.23 | -11.41 | -14.49 | -13.97 |
Normalized Diluted EPS | -1.07 | -1.38 | -1.91 | -2.35 | -2.64 |
Average Basic Shares Outstanding | 145.91M | 139.88M | 134.84M | 133.60M | 133.75M |
Average Diluted Shares Outstanding | 149.04M | 143.01M | 138.30M | 137.05M | 137.51M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |